Insulin is what economists would call a super inelastic product — no matter what the cost is, people are going to pay for it because it's a life saving medication. Two bills in Congress take aim at insulin prices — but one only targets co-pays for insured patients. Katherine Foley reports.
Learn more about your ad choices. Visit megaphone.fm/adchoices
